EVOK icon

Evoke Pharma
EVOK

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $666K invested in Evoke Pharma in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

31% less capital invested

Capital invested by funds: $966K → $666K (-$300K)

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$68.2K
2
+$586
3
+$91

Top Sellers

1
-$5.56K
2
-$113
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$407K
BL
2
Bleichroeder LP
New York
$189K
Citadel Advisors
3
Citadel Advisors
Florida
$68.2K
TRCT
4
Tower Research Capital (TRC)
New York
$586
BlackRock
5
BlackRock
New York
$336
SS
6
SBI Securities
Japan
$206
Morgan Stanley
7
Morgan Stanley
New York
$176
NA
8
NewEdge Advisors
Louisiana
$47
Bank of America
9
Bank of America
North Carolina
$25
UBS Group
10
UBS Group
Switzerland
–